Tenet’s high-acuity surgery mix cushions Q3 as uninsured pressure builds
Tenet Healthcare raised its 2026 earnings outlook after a quarter shaped by two opposing forces: softer overall surgical volume and stronger profitability from more complex procedures. The company’s strategy has been to lean harder into high-acuity surgeries such as joint replacements, advanced spinal fusions and robotic-assisted urological procedures, and that mix gave the operator room to absorb a weaker procedural backdrop. CEO Saum Sutaria told investors the surgical market was “not gangbusters right now,” but Tenet’s emphasis on specialized cases helped it weather the slowdown more effectively than many peers.
The quarter captured a familiar tension across hospital finance. Lower-volume elective care can drag on revenue, yet the cases that remain often skew toward patients with greater clinical need and higher reimbursement value. In Tenet’s case, that dynamic appears to have mattered more than a modest slide in procedure counts. Surgeries in its outpatient ambulatory and hospital units fell 1.5% and 1.1%, respectively, from the prior year, but earnings and margins still improved in both businesses.
Joint replacements drove the ambulatory lift
United Surgical Partners, Tenet’s ambulatory surgery arm, remains central to the company’s operating model. The unit now spans 535 ambulatory surgery centers and 25 surgical hospitals across 37 states, giving Tenet a broad platform for migrating more complex procedures into outpatient settings. In the third quarter, USPI performed 12.8% more total joint replacements than a year earlier. That increase helped the unit grow adjusted earnings before interest, taxes, depreciation and amortization by 9.1% to $537 million.
A higher share of orthopedic and other advanced procedures can change the economics of an ambulatory business quickly. Joint replacements require more resources than routine procedures, but they also typically carry stronger reimbursement and can fill operating rooms with patients who are less price-sensitive and more likely to proceed despite broader consumer caution. As hospitals and payers continue pushing care into outpatient settings, Tenet’s footprint is positioned to capture exactly the kind of case mix that protects margins when lower-acuity volumes soften.
One sentence explained the quarter better than any spreadsheet: fewer procedures did not translate into weaker earnings.
Exchange losses and more uninsured patients are reshaping the inpatient book
The operating backdrop was not uniformly favorable. For-profit systems have been feeling the effects of the expiration of enhanced premium tax credits on Affordable Care Act exchanges, a policy shift that has pushed more people to forgo coverage. Tenet is not insulated from that trend. Its exchange admissions and revenues both fell 18% year over year, accounting for 5.5% of net operating revenues, according to CFO Sun Park.
The pressure is not limited to exchange-related care. Tenet also saw an uptick in unpaid admissions across inpatient and outpatient visits during the quarter, a sign that more patients are arriving without reliable coverage or are unable to pay. In practical terms, hospitals face a harsher mix: fewer insured patients in some channels, more uncompensated care in others, and a growing need to manage sick patients who delayed treatment until their condition became harder and more expensive to address. Outpatient centers can avoid some of that burden because uninsured patients often defer routine or elective care entirely, but inpatient hospitals are left with a less predictable and often more costly population.
Sutaria said the effect of subsidy expiration was stabilizing in the third quarter compared with earlier in the year. Tenet did not disclose the exact earnings hit from exchange losses in the quarter, though the company had previously said it expected a $250 million earnings drag for the year from that trend. Stabilizing does not mean resolved. It simply means the headwind is no longer accelerating as quickly as it was when the coverage losses first began to show up in the company’s books.
The guidance bump also reflected a one-time contract windfall
Tenet’s improved outlook was not driven by surgery alone. A one-time benefit from the termination of CommonSpirit’s revenue cycle management contract also boosted third-quarter performance. Earlier this year, Tenet regained full ownership of Conifer Health after CommonSpirit agreed to pay $1.9 billion over three years to exit its services contract and bring revenue cycle functions in-house. The transition has now been pulled forward by two months, with completion set for Oct. 30.
That revenue cycle transaction is important because it adds a separate layer of support to Tenet’s financial profile. Cash flow, billing efficiency and contract windfalls can reinforce earnings momentum at the same time that procedure mix is helping margins. Yet the more durable story remains the clinical case mix. Joint replacements, cardiac care procedures and other complex surgeries are becoming increasingly important drivers of the company’s performance over the next couple of years, especially as care continues to migrate away from inpatient hospitals and into outpatient environments.
Tenet now expects full-year net income between $2.97 billion and $3.08 billion on operating revenues of $22.1 billion to $22.5 billion.
TD Cowen analysts described the underlying results as solid and slightly ahead of expectations, despite what remains a challenging fundamental backdrop for hospitals. That framing fits the quarter well. Tenet is benefiting from a deliberate tilt toward higher-acuity procedures, but it is doing so while contending with weaker elective demand, rising uncompensated care, and a payer mix that has become less forgiving.
The next test is whether the current mix of stronger orthopedic and specialized surgical volumes can continue offsetting the financial strain from uninsured patients and exchange losses without relying on one-time contract gains to keep the momentum intact.